Article citationsMore>>
Kitajima, R., Miyamoto, S., Tenjin, T., Ojima, K., Ogino, S., Miyake, N., Fujiwara, K., Funamoto, Y., Arai, J., Tsukahara, S,, Ito, Y., Tadokoro, M., Anai, K., Kaneda, Y. and Yamaguchi, N. (2012) Effects of Tapering of Long-Term Benzodiazepines on Cognitive Function in Patients with Schizophrenia Receiving a Second-Generation Antipsychotic. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 36, 300-306.
http://dx.doi.org/10.1016/j.pnpbp.2011.11.008
has been cited by the following article:
-
TITLE:
Case Reports: Treatment-Resistant Schizophrenia with Severe Type 2 Diabetes Mellitus Treated with Clozapine
AUTHORS:
Junji Gon, Shinji Sakamoto, Manabu Takaki
KEYWORDS:
Clozapine, Treatment-Resistant Schizophrenia, Type 2 Diabetes Mellitus, Brief Assessment of Cognition in Schizophrenia Japanese Version
JOURNAL NAME:
Open Journal of Psychiatry,
Vol.6 No.1,
January
11,
2016
ABSTRACT: Objective: Clozapine is
regarded as the most effective drug for treatment of schizophrenia but has
complex adverse effects associated with hyperglycemia and diabetes mellitus.
Method: We report that clozapine was very effective to treat positive,
negative, and cognitive symptoms and well tolerated to a treatment-resistant
schizophrenia patient with severe type 2 diabetes mellitus (DM) under cautious blood-sugar
monitoring. Results: Clozapine itself and discontinuation of other psychotropic
and anticholinergic agents after switching may improve cognitive function and
adherence to the treatment regimens for schizophrenia and DM. Conclusion:
Clozapine can be administered to treatment-resistant schizophrenia patients
even with severe DM with caution.
Related Articles:
-
Sopita Khamrod
-
Yasemin Gulecal, Mustafa Temel
-
Mohammed Adel Sharaf, Abdel-naby Saad Saad, Nihad Saad Abd El Motelp
-
Valerii Ermakov, Volodymyr Kolomoets, Leonid Panasyuk, Baja Orasgulyev
-
Zheng Yuan